Quarterly report pursuant to Section 13 or 15(d)

DERIVATIVE FINANCIAL INSTRUMENTS AND WARRANT LIABILITIES (Details Narrative)

v3.24.3
DERIVATIVE FINANCIAL INSTRUMENTS AND WARRANT LIABILITIES (Details Narrative) - USD ($)
 3 Months Ended 9 Months Ended
May 17, 2024
Nov. 17, 2023
Dec. 31, 2023
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Derivative Instruments, Gain (Loss) [Line Items]            
Gain (loss) on change in fair value of financial liabilities           $ 5,107,794
Gain on exercise of series B warrants         $ 165,355 0
Series A And B Warrants [Member]            
Derivative Instruments, Gain (Loss) [Line Items]            
Stock issuance costs     $ 1,451,249      
Series A Warrant [Member]            
Derivative Instruments, Gain (Loss) [Line Items]            
Gross proceeds from issuance of equity   $ 10,990,530        
Closing price         $ 8.32  
Fair value of warrant         $ 24.96  
Warrants outstanding         694  
Warrant liability         $ 17,245  
Series B Warrant [Member]            
Derivative Instruments, Gain (Loss) [Line Items]            
Gross proceeds from issuance of equity   $ 3,345,961        
Closing price $ 231.20          
Fair value of warrant $ 187.27          
Gain recognized on warrants         $ 2,174,673  
Change in fair value of warrants $ 3,405,662          
May 2023 Notes [Member]            
Derivative Instruments, Gain (Loss) [Line Items]            
Gain on fair value of conversion features       $ (690,290)   2,333,417
May 2023 Warrants [Member]            
Derivative Instruments, Gain (Loss) [Line Items]            
Gain on fair value of conversion features       $ 5,296   $ 2,774,377